Docket #: S23-057
Hydrogel injection for intestinal lengthening
Stanford scientists have developed a novel approach to help patients with short bowel syndrome by using intestinal lengthening. The solution involves injecting a degradable hydrogel into the intestinal wall to narrow the lumen and enable the confinement of a coiled spring. Currently, no devices are available for deploying inside the intestine to achieve this and existing methods necessitate surgical procedures to anchor the intestinal expanding device. However, as an injectable hydrogel, the solution facilitates endoscopic delivery of the coiled spring into the gastrointestinal tract. While the hydrogel solution enables strategically deploying devices within the gastrointestinal lumen for a transient duration, this approach may also be employed for drugs intended for a particular section of the gastrointestinal tract, anchoring the device near the area of interest instead of opting for systemic delivery.
Applications
- Minimally-invasive method for anchoring intestinal lengthening device (short bowel syndrome)
- Targeted drug delivery in the gastrointestinal tract
Advantages
- Lower need for surgical intervention
- Lower costs required for device placement
- Quicker recovery time
Related Links
Patents
- Published Application: 20240366501
Similar Technologies
-
Collagen-Based Hydrogels for Cell and Growth Factor Delivery S19-552Collagen-Based Hydrogels for Cell and Growth Factor Delivery
-
Controlled Release of Bacteriophage to Treat Implant Infections S20-117Controlled Release of Bacteriophage to Treat Implant Infections
-
Use of Focal Adhesion Kinase Inhibitors To Improve the Quality and Appearance of Split Thickness Skin Grafts S20-006Use of Focal Adhesion Kinase Inhibitors To Improve the Quality and Appearance of Split Thickness Skin Grafts